Nimbus
Techstars '25Alexandria, US · 2 known investors
HireNimbus is a mobile platform that connects homeowners with vetted local home service professionals for booking, payment, and job tracking. The company uses AI-driven matching to curate and recommend top-performing, owner-operated service providers.
Founders & leadership
SS
Satadru SenguptainFounder
Investors · 2
Competitors · 4
by search overlapNextdoor (NYSE: 2021)57 shared keywordsNeighborhood social network; IPO 2021
BuildZoom37 shared keywordsBuildZoom matches homeowners with local licensed contractors for construction and remodeling projects, using a database of over 160 million building permits and millions of contractor licenses along with a dedicated project consultant. It operates as a U.S. marketplace connecting property owners with vetted contractors and providing data-driven insights to guide hiring decisions.
BirdEye27 shared keywordsBirdeye offers an AI-powered platform with multi-agent "AI Coworkers" that handle marketing, operations, and customer experience tasks such as search optimization, review generation, listings management, social posting, and front-desk coordination. It serves multi-location businesses, providing a unified view of customers, locations, and interactions.
Porch9 shared keywordsPorch provides homeowners insurance through its reciprocal exchange and offers bundled home services including warranty coverage, moving assistance, and handyman services.
Companies competing with Nimbus for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
- Earnings call transcript: Nimbus Group posts stronger margins in Q2 2026 By Investing.cominvesting.com · 2026
- Nimbus Therapeutics raises $210 million in one of the larger fundraising rounds this yearstatnews.com · 2023
- Nimbus tacks on $210M in funding as investors swat away IRA concerns | Fierce Biotechfiercebiotech.com · 2023
- Nimbus raises $125M to advance rival to Bristol Myers’ new psoriasis drug | BioPharma Divebiopharmadive.com · 2022
- Nimbus raises $105M for multifront TYK2 clinical trial program | Fierce Biotechfiercebiotech.com · 2021